findmyKOL

Arlene Chapman, MD

Enriched profile

Professor of Medicine and Chief of the Section of Nephrology · University of Chicago

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Chicago, IL · Midwest · United StatesSpecialtyNephrologyFocusPolycystic Kidney Diseases+1
Active KOLfindmyKOL type: EliteLatest publicationNone indexedOnline presenceNone verifiedPayments2021–2025NIH funding2015–2026Why? →

Arlene Chapman is Professor of Medicine and Chief of the Section of Nephrology at University of Chicago. ClinicalTrials.gov lists 7 registered studies with this person as an investigator.

Data verified 19 Oct 2026

Overview

Updated 22 Oct 2026

Arlene Chapman is Professor of Medicine and Chief of the Section of Nephrology at University of Chicago. The public record shows 221 publications with 16,957 citations (h-index 65), centered on Polycystic Kidney Diseases, Polycystic Kidney, Autosomal Dominant. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 9 companies, 4 NIH-funded awards (2015–2026).

  • Top research focus: Polycystic Kidney Diseases
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cysts5 trialsPolycystic Kidney Diseases3 trialsHypertension2 trialsPolycystic Kidney, Autosomal Dominant2 trials

Research focus

OpenAlex concept fingerprint
Polycystic Kidney DiseasesPolycystic Kidney, Autosomal Dominant

Drugs & molecules

across trials, industry payments and publications
Jynarquegeneric · TolvaptanClinical trials—Industry payments2Publications—Auryxiageneric · Ferric citrateClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments6Emory UniversityClinical trials3Industry payments—National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Clinical trials2Industry payments—Vertex Pharmaceuticals IncorporatedClinical trials—Industry payments2Akebia Therapeutics IncClinical trials—Industry payments1Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1GlaxoSmithKline, LLC.Clinical trials—Industry payments1Janssen Research & Development, LLCClinical trials—Industry payments1Medtronic, Inc.Clinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1Palladio BiosciencesClinical trials1Industry payments—University of Kansas Medical CenterClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
65h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 2015–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 22 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 22 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    71.1%
    SGLT2 inhibitor71.1%
    Jardiance52%Farxiga48%
    Part D<11 patients
  • Cardiovascular

    28.9%
    ACE inhibitor28.9%
    Lisinopril-Hydrochlorothiazide100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 22 Oct 2026

4 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 22 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    mmp.bsd.uchicago.edu/steering-committee/arlene-chapman

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mmp.bsd.uchicago.edu ↗
  • Other

    profiles.uchicago.edu/profiles/display/5478543

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.uchicago.edu ↗
  • Other

    reachmd.com/cme/nephrology/investigator-interview-volume-progression-in-adpkd/12849

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
  • Other

    uchicagomedicine.org/find-a-physician/physician/Arlene-Chapman

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 22 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pkdcure.org ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pkdcure.org ↗
  • Member

    American Society of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
  • Member

    International Society of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
  • Member

    National Kidney Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
  • Member

    American Heart Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗

Awards & honors

honors on the public record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.